UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004197 |
|---|---|
| Receipt number | R000005044 |
| Scientific Title | Phase II Study of FOLFOX + Erbitux as first Line therapy in metastatic colorectal cancer with EGFR-detectable and KRAS wild type |
| Date of disclosure of the study information | 2010/09/13 |
| Last modified on | 2016/11/24 13:12:21 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/09/13 14:01:45 | ||
| 2 | Update | 2016/11/24 13:08:33 | Key inclusion criteria |
|
| 3 | Update | 2016/11/24 13:09:33 | Email Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 4 | Update | 2016/11/24 13:12:21 | Recruitment status Publication of results URL related to results and publications |
